Stage IA Breast Cancer Active Not Recruiting Phase 2 Trials for Trastuzumab (DB00072)

IndicationStatusPhase
DBCOND0029217 (Stage IA Breast Cancer)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02654119Cyclophosphamide, Paclitaxel, and Trastuzumab in Treating Patients With Stage I-II HER2/Neu Positive Breast Cancer After SurgeryTreatment
NCT00618657Carboplatin+Nab-paclitaxel, Plus Trastuzumab (HER2+) or Bevacizumab (HER2-) in the Neoadjuvant SettingTreatment